RadNet Inc
NASDAQ:RDNT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bloomage Biotechnology Corp Ltd
SSE:688363
|
CN |
|
S
|
Sebang Co Ltd
KRX:004360
|
KR |
|
Cybele Industries Ltd
BSE:531472
|
IN |
|
N
|
Nexalin Technology Inc
NASDAQ:NXL
|
US |
|
Bosideng International Holdings Ltd
HKEX:3998
|
HK |
|
T
|
Tuticorin Alkali Chemicals and Fertilizers Ltd
BSE:506808
|
IN |
|
H
|
Hwa Create Corp
SZSE:300045
|
CN |
|
China Galaxy Securities Co Ltd
SSE:601881
|
CN |
|
S
|
Seshasayee Paper and Boards Ltd
BSE:502450
|
IN |
|
Westwood Holdings Group Inc
NYSE:WHG
|
US |
|
K
|
Kuehne und Nagel International AG
XBER:KNIA
|
CH |
|
M
|
Mitsubishi Motors Corp
TSE:7211
|
JP |
|
C
|
China Fordoo Holdings Ltd
HKEX:2399
|
CN |
|
B
|
BMW Industries Ltd
BSE:542669
|
IN |
|
Zuari Agro Chemicals Ltd
NSE:ZUARI
|
IN |
|
V
|
VINX Corp
TSE:3784
|
JP |
RadNet Inc
Total Receivables
RadNet Inc
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
RadNet Inc
NASDAQ:RDNT
|
Total Receivables
$212.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
2%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Receivables
$1.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
5%
|
|
|
CVS Health Corp
NYSE:CVS
|
Total Receivables
$39.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
|
Cigna Corp
NYSE:CI
|
Total Receivables
$28.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Receivables
$2.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
5%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Total Receivables
$137.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
RadNet Inc
Glance View
RadNet Inc. stands as a formidable entity in the realm of diagnostic imaging services, charting its course as a crucial component within the broader healthcare sector. Founded in 1980, the company has evolved into a vital provider of outpatient imaging services across the United States, leveraging both organic growth and strategic acquisitions. RadNet operates a network of imaging centers, equipped with cutting-edge technology and staffed by experienced radiologists and technicians. These centers offer a range of diagnostic imaging procedures, including MRI, CT, mammography, X-ray, and ultrasound. By positioning itself at the intersection of healthcare efficiency and innovation, RadNet marries technology with patient care, optimizing the process of disease detection and diagnosis. Revenue streams for RadNet primarily flow from patient payments and insurance reimbursements for services rendered. With the increasing reliance on advanced imaging techniques in modern medicine, RadNet capitalizes on the demand for accurate, timely diagnostic data from healthcare providers aiming to enhance patient care protocols. Another key revenue avenue stems from partnerships with hospitals and healthcare systems, wherein RadNet provides the technical platform and expertise, thus enabling these institutions to focus on core patient care activities. This business model not only underscores the importance of diagnostic services in preventive and restorative healthcare but also sharpens RadNet’s competitive edge through scale, efficiency, and an extensive network of service locations.
See Also
What is RadNet Inc's Total Receivables?
Total Receivables
212.9m
USD
Based on the financial report for Dec 31, 2025, RadNet Inc's Total Receivables amounts to 212.9m USD.
What is RadNet Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
2%
Over the last year, the Total Receivables growth was -6%. The average annual Total Receivables growth rates for RadNet Inc have been 5% over the past three years , 9% over the past five years , and 2% over the past ten years .